19.11.2012 Views

Research Report 2000 - MDC

Research Report 2000 - MDC

Research Report 2000 - MDC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Folding and<br />

Misfolding of Proteins<br />

Gregor Damaschun<br />

The creation of proteins in living cells<br />

consists of two main processes:<br />

biosynthesis of the polypeptide chain<br />

and its folding into the native, threedimensional<br />

structure with biological<br />

function. The first process has been<br />

thoroughly studied, while the second<br />

process is less well known. We have<br />

learnt in recent years that the proteinfolding<br />

process is not always flawless<br />

within the cell and this can have<br />

pathological consequences. Thus, a<br />

number of human diseases are related<br />

to the deposition of protein fibrils<br />

causing tissue damage and<br />

degeneration. Amyloid fibrils develop<br />

from abnormal, misfolded<br />

conformational states of different<br />

normally soluble proteins forming<br />

ordered aggregates. The reasons for<br />

misfolding are unknown. Therefore,<br />

there are no causal treatments for<br />

these diseases. The group “Physics of<br />

Biopolymers” is engaged in studies of<br />

the folding pathways of proteins to<br />

understand the causes of misfolding.<br />

The main experimental methods used<br />

in these studies include solution X-ray<br />

scattering (SOXS), dynamic light<br />

scattering (DLS) and optical<br />

spectroscopy, including kinetic<br />

techniques. Methods of statistical<br />

physics of chain molecules have been<br />

applied to modelling the experimental<br />

data.<br />

46<br />

Polymorphism of proteins<br />

Textbooks state that the structure of a<br />

protein is determined by its amino<br />

acid sequence. However, we have<br />

been able to show experimentally that<br />

this so-called second genetic code is<br />

not unambiguous. The threedimensional<br />

structure of a protein is<br />

determined not only by the amino acid<br />

sequence but also by the environment<br />

of the protein molecules and is<br />

influenced by interactions between<br />

structural intermediates on the folding<br />

pathway. Therefore, many proteins<br />

can adopt differently folded threedimensional<br />

structures and only one<br />

of these structures is functionally<br />

active. For yeast phosphoglycerate<br />

kinase (PGK), we observed in<br />

addition to the native structure two<br />

further, different conformations. The<br />

starting point for the formation of<br />

these misfolded conformations is the<br />

acid-unfolded state. At low pH values,<br />

PGK has the conformation of an<br />

expanded random walk. If the<br />

molecule is transferred to a<br />

hydrophobic environment with a low<br />

dielectric constant, the entire molecule<br />

forms α-helix. On the other hand,<br />

anion-induced partial refolding of the<br />

acid-unfolded state leads to the<br />

formation of amyloid-like fibrils. Half<br />

the amino acids have the conformation<br />

of a cross-β-helix which is typical of<br />

all amyloids.<br />

Folding pathways and kinetics<br />

The formation of amyloids starts from<br />

non-natively folded monomeric<br />

intermediates. The monomers<br />

aggregate forming successively<br />

dimers, tetramers and octamers. More<br />

and more cross-β-structure develops<br />

during this aggregation process. The<br />

kinetics of aggregation is strongly<br />

dependent on protein concentration.<br />

At room temperature, this process<br />

may take several hours. Subsequently,<br />

the octamers grow in one direction<br />

only and form fibrils. The growth of<br />

the fibrils, i.e. their time-dependent<br />

elongation, may take some months.<br />

Our results indicate that inhibitors of<br />

cross-β-structure formation can be<br />

effective only during the early phases<br />

of amyloidosis. The slow kinetics are<br />

typical of misfolding of proteins into<br />

amyloids. In vivo, the progression of<br />

these processes is in some cases even<br />

slower than in our in vitro experiments.<br />

By contrast, the folding of a protein<br />

into its native structure is a fast<br />

process. Typical times for folding vary<br />

from milliseconds to minutes. One<br />

central problem in protein folding is<br />

the question, whether chain segments<br />

with a periodic secondary structure<br />

develop in a first step, then form in a<br />

second step the compact globule<br />

through diffusion (framework model),<br />

or whether the chain initially<br />

collapses, driven by hydrophobic<br />

interactions, with concurrent or<br />

subsequent formation of segments<br />

with periodic secondary structure<br />

(hydrophobic collapse model). We<br />

have been able to show experimentally<br />

that both models are not general<br />

alternatives. There are proteins folding<br />

mainly according to the mechanism of<br />

the framework model (e.g., bovine<br />

RNase A) as well as folding according<br />

to the hydrophobic collapse model<br />

(e.g., bovine α-lactalbumin). Further<br />

studies are necessary to address the<br />

open question: which of these folding<br />

scenarios is more prone to the<br />

misfoldings that lead to amyloids?<br />

Up to now, a search for common<br />

properties of amyloid-forming<br />

proteins has been unsuccessful.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!